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Dr James I. Fann (Stanford, Calif). I compliment you on awon-
derful presentation and a very interesting paper. You and your col-
leagues are to be congratulated for taking on the challenge of
clarifying the outcomes of on-pump (conventional CABG) versus
off-pump (OPCAB) approach to coronary revascularization in an
elderly patient population of nearly 2000 octogenarians over
a recent 6-year period.
The distribution of patients undergoing OPCAB was similar to
the national average at approximately 20%. Given the retrospec-
tive nature of the analysis, the patients were remarkably similar ex-
cept for age, incidence of preoperative atrial fibrillation, stroke,
and the incidence of class IV functional class, all of which were
slightly to moderately higher in the OPCAB group. Your analysis
showed that despite more postoperative complications in the con-
ventional CABG group, the operative mortality rates and hospital
costs were similar between the groups. Your conclusion that OP-
CAB coronary revascularization should be considered as an ac-
ceptable alternative to the conventional CABG approach in
elderly patients seems to be reasonable, but there are some issues
that need to be clarified and may increase the impact regarding
previous and potentially future decision-making.
I will limit my questions to 3 main categories. First is the issue
of number of grafts. Forty-six percent or nearly half the patients in
the OPCAB group had 1- or 2-vessel disease compared with 16%
in the conventional CABG group. Stated another way, 84% of the
patients in the conventional CABG group had 3-vessel disease
compared with slightly over half (54%) in the OPCAB group.
Hence, the patient cohorts are different. The question is, how do
you think the number of needed grafts affected patient selection
and how would you compare this finding of fewer grafts in the
OPCAB group with what others have reported?
Dr LaPar. Thank you very much for those kind comments,
Dr Fann. As you identified, clearly there is a selection bias as
we concluded in patients who were being selected for OPCAB,
and the selection bias does clearly select out patients requiring
fewer numbers of grafts and having less multivessel disease. Our
data show that and are consistent with what has been reported else-
where in previous studies as well.
Dr Fann. Second, the incidence of postoperativemyocardial in-
farction was low overall, but this complication was significantly
higher in the OPCAB group at 1.2% compared with 0.3% in the
conventional CABG cohort. Although this higher incidence might
not have affected the overall mortality, it is of concern, and it is im-
portant to know the outcome of these 5 patients. For instance, what
was the extent of the myocardial infarction? What were the diag-
nostic criteria for the myocardial infarction? Were the grafts pat-
ent? Did any patient require reoperation, percutaneous
intervention, or intra-aortic balloon pump placement? How
many of these cases were fatal?
Dr LaPar. You are absolutely right. Although we did not pres-
ent it in this presentation, the perioperative myocardial infarctionry c January 2011
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Drate was slightly higher within the OPCAB group but statistically
significant. As you pointed out, 5 patients within the OPCAB
group, that is, 5 of 404 patients, did have postoperative myocardial
infarction. Unfortunately, owing to the de-identified nature of our
data set, we are unable to completely track out all of the events of
that myocardial infarction. However, I can tell you that among
those 5 patients, 4 did actually contribute to the operative mortal-
ity, so 4 did die. That is, 80% of that small group of patients did die.
Dr Fann. Third, a major conclusion is that OPCAB confers
a lower major complication rate. When assessing the components
of the composite score of major complications, prolonged ventila-
tion comprises the bulk of the difference between the 2 groups in
terms of major complications. This finding is not surprising given
what we know about the effects of CPB. Can you define how long
is prolonged? That is, is it 24 hours, 2 days, or 3 days? Regarding
this complication, the postoperative length of stay between the 2
groups was similar in this study. Thus it is important to know
the definition and significance of prolonged ventilation inasmuch
as it really did not appear to have any clinical sequela in terms
of length of hospital stay and had no impact on overall cost.
Also missing in the preoperative assessment is the incidence of
chronic obstructive pulmonary disease. Is it possible that the
conventional CABG group had a higher incidence of pulmonary
disease, thereby accounting for the difference in the prolonged
ventilation?
DrLaPar. I think you are absolutely right in that when we break
down the composite components of major complications, the high-
est component of that and the biggest contributor was prolonged
ventilation. Prolonged ventilation in this study was defined by
the STS definition as being more than 24 hours of ventilation after
surgery. The influence of that on our composite incidence is clear.
Postoperative ventilation has been shown in the past, especially
within other randomized trials such as the Octopus trial, to be in-
dependently influenced by the use of CPB. Although there are
many factors that may contribute to prolonged ventilation, I still
think that is a valid postoperative complication that does in fact af-
fect patient care. Although in our study we did not demonstrate any
true correlation between the prolonged ventilation and prolonged
intensive care unit or total hospital length of stay, other studies
in the past have shown that prolonged ventilation does in fact con-
tribute to greater resource use and longer patient stays in the hos-
pital. We should definitely try to answer that question more clearly
in the future.
Dr John C. Chen (Honolulu, Hawaii). I want to ask you to ad-
dress the issue of fewer grafts in greater depth. One of the things
that we have been raised to believe in is that surgical mortality
is important, that to have a live patient is perhaps one of the biggest
things we strive for. Our cardiologist colleagues, unfortunately, do
not have the same view at times. They are more interested in num-
ber of grafts that we implant because they believe that the graft
number is important to the patient’s outcome. One of the things
we are looking at is long-term outcome, 5-year survival, in our co-
hort of conventional CABG and OPCAB patients. Are you looking
at that or do you have any plans to look at that to address questions
from our cardiology colleagues?
Dr LaPar. You bring up a very good point. The question of
long-term graft patency and number of grafts and completeness
of revascularization between conventional CABG and OPCABThe Journal of Thoracic and Cand just coronary bypass grafting in general compared with
some of our interventional techniques is very important. In this
study, unfortunately, we were not able to look at any long-term
data because of the de-identified nature of our data set; however,
with regard to the question of graft patency and 5-year long-
term survival within an extreme elderly population such as the oc-
togenarians, I am not quite sure howwell we are going to be able to
answer that in even a small multicenter trial. We need to evaluate
a very large cohort of patients over a very long period of time to
more clearly answer that question, but I certainly am interested
in following up and trying to answer that question.
Dr James Douglas (Bellingham, Wash). Thank you, Dr LaPar.
That was an excellent study, very well presented. For some time I
have had the feeling that in current-day practice of OPCAB sur-
gery, we have been essentially asking the wrong question. I think
your study really highlights that. The question is not whether OP-
CAB is better than conventional CABG, but rather in which pa-
tients is OPCABG better than conventional CABG and vice
versa. Being someone who has been a practitioner of OPCAB
for quite some time, experience has shown me that not everybody
benefits equally. When we try to do randomized studies and in-
clude everybody as if they are equally amenable to it, I think we
make an error in judgment.
The second question that we have not asked appropriately is,
who should be dong OPCAB surgery? It is a different skill set.
Like any of the procedures that we do with a different skill set,
those who are better at the particular skill set will get better results.
Studies have shown that the most improvement with OPCAB sur-
gery has been from those institutions in which the staff has the
most personal experience.
The question I would really like to ask, though, is related to
a different point. I notice that in your paper, as in so many others,
there is a trend toward an improvement in the risk of postoperative
stroke in patients with OPCAB, although it did not reach statistical
significance. One thing that has been very clear from the literature
for many years is that the predominant factor for postoperative
stroke is ascending aortic atherosclerosis. Regardless of whether
you do OPCAB or conventional CABG, if you do not manage
that ascending aorta appropriately you are going to have an in-
creased likelihood of embolization and postoperative stroke.
NowCPB probably has a component to contribute to postoperative
stroke, but it is not the only one and I do not think it is the major
one. Therefore, I do not think it is surprising that the overall inci-
dence was a trend toward it but not absolute. My question revolves
around any evidence that you might have from the VCSQI or
whether the data are available to determine how people manage
the aorta. Would it be feasible to look at the postoperative stroke
outcome in the patients who had specific techniques designed to
prevent perioperative embolization?
Dr LaPar. Thank you very much for that question. Obviously,
patient risk stratification is a very important component in trying to
further define which patients are better served by OPCAB, and
stroke is one of those things that we need to more clearly identify.
Unfortunately, the VCSQI does not have any long-term data or
any sort of data, in fact, that might be able to help us answer how
other practicing surgeons in other institutions are managing the
ascending aorta or in the preoperative, perioperative, or intraoper-
ative setting in making those decisions. I can speak for ourardiovascular Surgery c Volume 141, Number 1 89
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Dinstitution. In almost every patient in whom we use any sort of
CPB, we use primarily aortic ultrasound intraoperatively to survey
the cannulation sites or just the ascending aorta in general. In cer-
tain patients we are starting to use increasingly preoperative com-
puted tomographic angiography to look at calcification and the
burden of the ascending aorta. Unfortunately, with the VCSQI
we are not able to comment on what some of the other centers
are doing, but that is certainly an important point.
Dr James Brevig (Everett, Wash). I noticed that you had sub-
stantially higher blood use in your conventional CABG cases
than in the OPCAB cases. I also noticed that many of the outcomes
that we have been discussing in terms of mortality, length of stay,
intubation time, and other complications are also associated with90 The Journal of Thoracic and Cardiovascular Surgepacked cell transfusion. What do you think your results would
have looked like if you had a lower transfusion rate in your patients
undergoing conventional CABG?
Dr LaPar. That is a very important point. I personally think that
a major component to the prolonged ventilation occurring in our
conventional CABG pump patients is likely influenced by that in-
creased transfusion requirement and a transient acute lung injury
that may have occurred as a result. That has been a focus of our
basic science laboratory for many years, looking at that effect. If
the transfusion requirements were to be decreased, we probably
would not see as much of an influence on prolonged ventilation,
and it may have helped make our overall morbidity among the
2 patient cohorts much more balanced.ry c January 2011
